TOULOUSE, France–(BUSINESS WIRE)–Regulatory News: VEXIM (Paris:ALVXM) (FR0011072602 ‐ ALVXM / PEA-PME), a medical device company specializing in the minimally invasive treatment of vertebral fractures, announced today its consolidated financial results for the year that ended on December 31st, 20151. Fast and sustained business growth In 2015, VEXIM had a turnover of €13.9 million, up 34% compared to […]